US health agency advises reconsidering travel to Congo amid virus outbreak

The US Centers for Disease Control and Prevention (CDC) has issued a Level 3 travel health notice for the Democratic Republic of the Congo (DRC), advising travellers to reconsider non-essential travel to the region. The advisory follows the confirmation of an outbreak of Bundibugyo virus disease (BVD) in the Ituri and Nord-Kivu provinces.

Bundibugyo virus disease is classified as a type of Ebola disease, caused specifically by infection with the Bundibugyo virus. The CDC’s Level 3 classification indicates significant health risks, urging travellers to exercise caution rather than simply taking standard precautions. This stands in contrast to lower-level notices, such as recent guidance on global dengue risk, which advises travellers to maintain usual preventive measures without avoiding travel.

The current outbreak is concentrated in the Ituri and Nord-Kivu provinces. While the CDC has identified the specific pathogen responsible, the agency’s statement does not provide details regarding the number of confirmed cases, the timeline of the outbreak’s onset, or the current status of containment efforts within these areas.

It is important to note that this advisory reflects the risk assessment of the US government. The CDC’s guidance may not align with the assessments of local DRC health authorities or other international bodies. Furthermore, while BVD is a form of Ebola disease, it is distinct from other Ebola virus species, such as Zaire ebolavirus, and transmission dynamics can vary between these types.

The advisory remains in effect as the situation develops. Travellers with plans to visit the affected provinces are advised to review the specific health risks associated with Bundibugyo virus disease and consider the implications for their itineraries.